Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 882 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Hanmi enters into supply contract with MEIC

Products for licensing include Ten Ten, Dexibuprofen ER & Syrup, Medilac probiotics for children, CeCe multi-vitamins, Prebe multi-vitamins for pregnant women, and Ferromax antianemic agent. The registration process

Navidea enters licensing deal with Alseres

[123I]-E-IAFCT Injection also called Altropane, is a patented, novel, small molecule radiopharmaceutical that binds to the dopamine transporter (DAT) on the cell surface of dopaminergic neurons in the

Vaxiion receives US patent for minicell-based therapeutics

The patent covers compositions of matter related to the antibody-based targeted delivery of biologically active compounds (including therapeutics) using Vaxiion’s minicell-delivery platform technology. Vaxiion’s targeted therapeutic delivery platform

UCB epilepsy drug wins FDA clearance

Keppra was previously approved in the US as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy. The approval